Trial Profile
A study on efficacy and safety of a DPP-IV inhibitor in type 2 diabetes patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms S-DOG
- 21 Feb 2012 New trial record